LIXTE Biotechnology advances colon cancer treatment with Roche and Netherlands Cancer Institute

LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW), a trailblazer in clinical stage pharmaceutical development, has embarked on a groundbreaking clinical trial in partnership with ... Read More